Abstract
In critical care medicine, dopamine is used for treatment and prevention of circulatory insufficiency and shock [5, 7, 13, 20]. At low doses (2 to 5 µg/kg per min) renal blood flow and sodium excretion are increased [1, 5, 6, 12, 13, 14, 18, 19, 22]; these effects are attributed to the action of specific dopamine receptors [5, 16, 23]. At higher doses (5 µg/kg per minute), sympathic β1 - and α-receptors are stimulated, so that cardiac output and (especially at doses over 10 µg/kg per min) vascular resistance are increased [5, 6],
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barnado, D.E., Baldus, W.P., Maher, F.T.: Effects of dopamine on renal function in patients with cirrhosis. Gastroenterology 58 (1970) 524–528
Cavero, I., Massingham, R., Lefevre-Borg, F.: Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part I: subclassiflcation and functional description. Life Sciences 31 (1982) 939–948
Fleckenstein, W., Weiss, Ch.: A comparison of PO2-histograms from rabbit hindlimb muscles obtained by simultaneous measurements with hypodermic needle electrodes and with surface electrodes. Adv. Exp. Med. Biol. 169 (1984) 447–455
Fleckenstein, W., Weiss, Ch.: Ein neues Gewebe-pO2-Me6verfahren zum Nachweis von Mikrozirkulationsstorungen. Focus MHL1, Heft 2 (1984) 74–84
Goldberg, L.I.: Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol. Rev. 24 (1972) 1–29
Goldberg, L.I.: Dopamine - clinical uses of an endogenous cathecholamine. New Eng. J. Med. 291 (1974) 707–710
Gunar, R., Lieb, H., Pietras, R., Dritz, J., Tobin Jr., J.: Hemodynamic effects of dopamine compared to norepinephrine and isoproterenol in clinical shock. Circulation 37/38. Supp. VI (1968) 6
Higgins, C.B., Millard, R. W., Braunwald, E., Vatner, S.F.: Effects and mechanisms of action of dopamine on regional hemodynamics in the conscious dog. Am. J. Physiol. 225 (1973) 432–437
Jackson, L. K., Key, B. M., Cain, S. M.: Total and hindlimb O2 uptake and blood flow in hypoxic dogs given dopamine. Crit. Care. Med. 10 (1982) 327–331
Kessler, M.: Lebenserhaltende Mechanismen bei Sauerstoffmangel und bei Störungen der Organdurchblutung. Mitt. Max-Planck-Ges. (1974) 444–463
Laubie, M., Schmitt, H., Falq, E.: Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect. Europ. J. Cardiol. 42 (1977) 307–310
Leier, C. V., Heban, P.T., Huss, P., Bush, C. A., Lewis, R. P.: Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58 (1978) 466–475
Loeb, H.A., Einslow, E.B., Rahimtoolla, S.H., Rosen, K.M., Gunnar, R.M.: Acute hemody-namic effects of dopamine in patients with shock. Circulation 154 (1971) 163–173
Maskin, C.S., Kugker, J., Sonnenblick, E.H., Lejemtel, T.H.: Acute inotropic stimulation with dopamine in severe congestive heart failure: Beneficial effect at rest but not during maximal ex-ercise. Am. J. Cardiol. 52 (1983) 1028–1032
McCannell, K. L., Giraud, G. F., Hamilton, P. L., Groves, G.: Hemodynamic responses to dopamine and dobutamine infusion as a function of duration of infusion. Pharmacology 26 (1983) 29–39
McNay, J.L., McDonald, R.H., Goldberg, L.I.: Direct renal vasodilation produced by dopamine in the dog. Circul. Res. 16 (1965) 510–517
Mostbeck, A., Pratsch, H., Peschl, L.: Der Einfluß von Dopamin auf die regionalen Blutvolumina in Leber, Abdomen, Thorax und Extremitäten. Wiener Klin. Wschr. 89 (1977) 505–512
Mostbeck, A., Peschl, L., Schüller, J., Neumayr, A.: Simultane Untersuchungen von Funktionsparametern der Leber und der Niere unter dem Einfluß von Dopamin. Wiener Klin. Wschr. 87 (1975) 639–642
Ramdohr, B., Biamino, G., Schröder, R.: Vergleichende Untersuchungen über die Wirkung von Dopamin und Orciprenalin am gesunden Menschen: Muskeldurchblutung, Nierendurchblutung, Nierenfunktion. Klin. Wschr. 50 (1972) 1499–157
Ramdohr, B., Biamino, G., Schüren, K. P., Schröder, R.: Dopamin bei der Behandlung der akuten schweren Herzinsuffizienz. Med. Welt 26 (1975) 540–546
Scheoeder, W.: Die Messung des Sauerstoffdruckes in der Skelettmuskulatur - eine quantitative Methode zur Kontrolle der Sauerstoffversorgung und der Funktion der terminalen Muskelstrombahn. Herz/Kreisl. 10 (1978) 146–153
Talley, R.C., Forland, M., Beller, B.: Reversal of acute renal failure with a combination of intravenous dopamine and diuretics. Clin. Res. 18 (1970) 518–522
Yeh, B., McMay, J.L., Goldberg, L.I.: Attenuation of dopamine on renal and mesenteric vasodilation by haloperidol: evidence for specific dopamine receptor. J. Pharmacol. Exper. Ther. 168 (1969) 303–309
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kersting, T., Reinhart, K., Fleckenstein, W., Dennhardt, R., Eyrich, K., Weiss, C. (1987). Tissue PO2 Measurements in Critical Care: The Effects of Dopamine on Muscular Oxygen Pressure Fields. In: Ehrly, A.M., Hauss, J., Huch, R. (eds) Clinical Oxygen Pressure Measurement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71226-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-71226-5_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71228-9
Online ISBN: 978-3-642-71226-5
eBook Packages: Springer Book Archive